F-Prime Capital是一家总部位于马萨诸塞州的全球风险投资机构。该机构成立于1946年,专注于医疗保健和医疗技术领域。作为全球最大的资产管理机构之一,该机构管理资产超过2万亿美元。
公司 | 轮次 | 金额 | 投资时间 | 机构 | |
---|---|---|---|---|---|
昂阔医药 | A轮 | 1亿美元 | 2024-01-04 | Novo Holdings Marshall Wace Forge Life Science Partners CJNV BioVentures OrbiMed Catalio Capital Management Blackbird 博远资本 F-Prime Capital Sofinnova Investments | Novo Holdings Marshall Wace Forge Life Science Partners CJNV BioVentures OrbiMed Catalio Capital Management Blackbird 博远资本 F-Prime Capital Sofinnova Investments |
昂阔医药 | A轮 | 1亿美元 | 2024-01-04 | F-Prime Capital Sofinnova Investments Catalio Capital Management Forge Life Science Partners Blackbird CJNV BioVentures 博远资本 Novo Holdings OrbiMed Marshall Wace | F-Prime Capital Sofinnova Investments Catalio Capital Management Forge Life Science Partners Blackbird CJNV BioVentures 博远资本 Novo Holdings OrbiMed Marshall Wace |
ARTBIO | 种子轮 | 2300万美元 | 2023-06-21 | F-Prime Capital Omega Funds | F-Prime Capital Omega Funds |
Albert Invent | 种子轮 | 750万美元 | 2023-06-14 | F-Prime Capital Index Ventures Homebrew | F-Prime Capital Index Ventures Homebrew |
Tenpoint Therapeutics | A轮 | 7000万美元 | 2023-07-14 | F-Prime Capital UCL Technology Fund Sofinnova Partners 启明创投 Eight road Ventures British Patient Capital | F-Prime Capital UCL Technology Fund Sofinnova Partners 启明创投 Eight road Ventures British Patient Capital |